Find Academic Supervisors

Harris H. Wang is an Associate Professor in the Department of Systems Biology and Department of Pathology and Cell Biology at Columbia University's Vagelos College of Physicians and Surgeons, where he also serves as Interim Chair of Systems Biology. He is affiliated with the Center for Computational Biology and Bioinformatics (C2B2) and the Integrated Program in Cellular, Molecular and Biomedical Studies (CMBS). B.S., Physics and Mathematics, MIT Ph.D., Biophysics, Harvard University Dr. Wang's research lies at the intersection of systems and synthetic biology, focusing on developing foundational technologies for genome engineering, microbiome manipulation, and synthetic genomics. His lab pioneers methods such as MAGE, MAGIC, CAST, and CAMII to enable high-throughput genetic manipulation, in situ microbiome engineering, and AI-driven microbial culturomics. Key research themes include understanding microbial community dynamics, engineering cellular memory systems, designing biocontained genetic circuits, and applying synthetic biology to human health challenges in personalized medicine and infectious disease. His recent publications reveal a strong trend in spatial and functional metagenomics, CRISPR-based microbiome editing, and synthetic biology tools for data storage and genetic stability. The articles span high-impact journals like Nature , Science , and Nature Biotechnology , reflecting his leadership in developing scalable, programmable biological systems. Scientific Awards: NIH Director’s Early Independence Award Forbes 30 Under 30 in Science Sloan Research Fellowship NSF CAREER Award ONR Young Investigator Award Burroughs Wellcome Fund PATH Award Schaefer Scholar Blavatnik National Award Vilcek Prize PECASE Dr. Wang has advised numerous PhD and postdoctoral researchers, many of whom have gone on to independent scientific careers. His lab is supported by major grants from NIH, NSF, DARPA, DOE, and foundations including the Bill & Melinda Gates Foundation and CZ Biohub NY. He is actively involved in educational initiatives, including organizing Columbia’s iGEM team and the Cold Spring Harbor Laboratory Synthetic Biology course. The Wang Lab is based at the Columbia University Irving Medical Center and is part of national consortia such as the Engineering Biology Research Consortium (EBRC) and the Genome Project-Write (GP-Write) initiative. The lab develops and applies cutting-edge technologies in automation, machine learning, and synthetic biology to engineer microbiomes for applications in medicine, global health, and climate change.

• Systems Biology
• Synthetic Biology
• Genome Engineering
• +17 more

Hauke Smidt is a Personal Professor at Wageningen University & Research, affiliated with the Molecular Ecology group within the Faculty of Veterinary Medicine and Animal Sciences. His research focuses on microbial ecology, particularly gut microbiota dynamics, antibiotic resistance, environmental microbiology, and the One Health framework. Smidt has supervised over 50 PhD students and contributed to 519 publications, including studies on microbiome resilience, fermented food impacts, and bioremediation strategies. Education and affiliations include leadership roles in projects addressing antimicrobial resistance, pig health, and drinking water microbiology. His work spans collaborations across Europe and Asia, with notable contributions to understanding microbial community responses to environmental stressors and dietary interventions. Smidt is actively involved in public outreach, as seen in media contributions discussing microbiome research and health benefits. Key projects include aquifer treatment for drinking water, microbiome simulation models, and combating plant pathogens. His awards and recognition are not explicitly listed, but his extensive publication record and project leadership highlight significant academic impact.

• Microbiology
• Environmental Microbiology
• Gut Microbiota
• +4 more

Dr. Keith Alexander Sharkey is a Professor in the Department of Physiology and Pharmacology at the Cumming School of Medicine, University of Calgary. He is also a Full Member of both the Hotchkiss Brain Institute and The Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases. Dr. Sharkey has been at the University of Calgary since his appointment as Assistant Professor in 1990, dedicating his career to understanding the neural control of the gastrointestinal tract. From 2005-2021, he held the Crohn's and Colitis Canada Chair in Inflammatory Bowel Disease Research, demonstrating his longstanding commitment to advancing knowledge in gastrointestinal sciences. Dr. Sharkey's educational journey began with a BSc (Hons) in Nutrition from the University of London in 1981, followed by a PhD in Physiology from the University of Liverpool in 1985. After completing postdoctoral training in Hungary, the UK, and Canada, he joined the University of Calgary faculty in 1990, where he has remained throughout his distinguished academic career. Dr. Sharkey's research program centers on understanding the physiology and pathophysiology of the neural control of the gastrointestinal tract and brain-gut interactions in health and disease. His laboratory investigates two main areas: the role of the endocannabinoid system in regulating GI motility and intestinal barrier function, and the physiology of the enteric nervous system in controlling motility and barrier function. His work employs state-of-the-art approaches including live cell imaging and molecular genetics. Recent publications show his expanding interest in connections between gut function and neurodegenerative conditions like ALS, with multiple 2024-2025 papers examining sexual dimorphism in disease processes and gut-brain axis mechanisms. Fellow, Royal Society of Canada (2024) Cumming School of Medicine's van de Sande Distinguished Achievement Award for Mentorship (2021) Distinguished Research Award, American Physiological Society (2021) Finkelstein Award for Excellence, Crohn's and Colitis Canada (2016) Fellow, Canadian Academy of Health Sciences (2015) Fellow, Canadian Association of Gastroenterology (2015) Killam Annual Professor Award, University of Calgary (2013) Dr. Sharkey has mentored numerous students throughout his career, as evidenced by his 2021 Mentorship Award. His research is supported by significant funding, including a CIHR Foundation grant exploring how enteric nerves and glia maintain intestinal homeostasis. He has also participated in university strategic initiatives focused on Brain and Mental Health (2015-2021) and Infections, Inflammations and Chronic Diseases (2015-2021), demonstrating his interdisciplinary approach. The Sharkey Lab provides a safe, inclusive, and diverse research environment that encourages open scientific exchange from diverse viewpoints. His laboratory is actively engaged in multiple collaborative projects, including investigations with UBC Okanagan on diet and probiotics targeting the gut-brain metabolic interactome, and with University of Calgary colleagues studying gut microbiota's role in ALS. Dr. Sharkey continues to advance our understanding of neural mechanisms controlling gastrointestinal function with upcoming courses scheduled for Fall 2024 and Winter 2025.

• Enteric nervous system
• Gut-brain axis
• Endocannabinoid system
• +3 more

Vincent Quagliarello, MD, is Professor of Medicine in the Department of Infectious Diseases at Yale School of Medicine, where he also serves as Clinical Chief of Infectious Diseases and Vice Chair for Education and Academic Affairs in the Department of Internal Medicine. His research focuses on infections among older adults, with particular expertise in endocarditis, meningitis, and antimicrobial stewardship in geriatric populations. Dr. Quagliarello has been an NIH R01-funded principal investigator studying infections in older adults and received an NIH K07 Academic Leadership Award to mentor postdoctoral trainees and junior faculty. His publication record demonstrates consistent focus on antimicrobial use in elderly patients, particularly those with advanced cancer, nursing home residents, and end-of-life care scenarios. His research has significantly contributed to understanding appropriate antimicrobial therapy in geriatric populations and the management of infections in complex elderly patients. Scientific Awards: Clinical Teacher Award (2011) from Infectious Diseases Society of America Leah Lowenstein Award (2007) from Yale School of Medicine Department of Internal Medicine Teacher of the Year (1998, 1990) Laureate Award (1997) from American College of Physicians (CT Chapter) Bohmfalk Teaching Prize (1997) from Yale School of Medicine Dr. Quagliarello has served as an educational leader at Yale, directing the Internal Medicine Clerkship, the Yale Infectious Diseases Fellowship program, and creating the Department of Medicine Research in Residency Program. His clinical work spans the spectrum of infectious diseases with a special focus on public health impact.

• Infectious Diseases
• Geriatric Infectious Diseases
• Antimicrobial Stewardship
• +7 more

Aisha Ameen is a Researcher in the Department of Veterinary and Animal Sciences (Pathobiological Sciences) at the University of Copenhagen's Faculty of Health and Medical Sciences, holding dual appointments as Research Assistant and Guest Researcher. Her research centers on Alzheimer's disease mechanisms with emphasis on astrocyte metabolism, glucose/glutamate dynamics, and short/medium-chain fatty acid roles. She employs functional metabolic mapping, dMRI, immunohistochemistry, and hiPSC models to investigate neurodegenerative processes at cellular and systemic levels. Analysis of her 2022-2025 publications reveals consistent focus on metabolic dysregulation in Alzheimer's pathology, particularly astrocyte energy substrate competition and fatty acid interventions. Her work bridges neuroscience, metabolism, and translational disease modeling with significant citation impact and media attention.

• Neuroscience
• Alzheimer's Disease
• Metabolism
• +2 more

Natalie H. Brito is an Associate Professor of Applied Psychology at New York University (NYU), affiliated with the Steinhardt School of Culture, Education, and Human Development. Her research focuses on how early social and cultural contexts shape neurocognitive development in infants and toddlers, particularly in areas of attention, memory, and socio-emotional skills. Prior to NYU, she completed a postdoctoral fellowship at Columbia University Medical Center and was a Robert Wood Johnson Health and Society Scholar. Dr. Brito’s work bridges developmental psychology, neuroscience, and public policy, emphasizing the need for equitable environments that support healthy child development. She has received prestigious awards such as the APS Rising Star Award and NIH grants, reflecting her impactful contributions to understanding developmental trajectories. Her research also extends to policy implications, such as the effects of paid maternal leave on infant brain function and the role of structural inequities in maternal mental health. Key themes include early life stress, gut microbiome influences, and the neurobiological underpinnings of cognitive development. Dr. Brito has published extensively in journals like Child Development , Developmental Cognitive Neuroscience , and JAMA Psychiatry , with a focus on innovative methodologies (e.g., the OWLET gaze-tracking tool). She teaches courses on developmental psychology and the principles of applied psychology, fostering interdisciplinary approaches to human development. Her scientific accolades include recognition from the International Society of Developmental Psychobiology and the American Psychological Association, underscoring her leadership in advancing developmental science and equity-focused research.

• Developmental Psychology
• Neurocognitive Development
• Early Childhood Development
• +3 more

Claus Lamm is a Full Professor of Biological Psychology at the University of Vienna , where he leads the Social, Cognitive and Affective Neuroscience Unit (SCAN-Unit) . He serves as Vice Dean for Research and Advancement of Early Career Researchers at the Faculty of Psychology and holds affiliations with the Vienna Cognitive Science Hub , Environment & Climate Change Hub , and Austrian Academy of Sciences . His academic career spans international collaborations and formative research experience abroad. Scientific Focus: Lamm investigates the neural underpinnings of empathy and prosocial behavior , employing multi-modal approaches combining neuroimaging, psychopharmacology, and psychoneuroendocrinology . His work extends to comparative studies with ravens and dogs, and explores environmental social neuroscience through climate change decision-making research. Recent publications show trends in cross-cultural psychology , machine learning applications , and neurobiological pathways related to social behavior. Awards & Grants: Recipient of the APS Mentor Award for his support of early career researchers. Funded by European Research Council , Austrian Science Fund , Vienna Science and Technology Fund , and intramural grants exceeding €10 million. Key projects include "Unravelling the opioid system in empathy" and "Comparative dog-human fMRI" . Media Engagement: A prominent public science communicator, Lamm has appeared in Nature , Science Magazine , and Austrian media outlets like Ö1 Mittagsjournal and ORF2 , discussing topics from pandemic psychology to social media effects . He maintains active outreach through Science TV and educational programs .

• Empathy
• Prosocial Behavior
• Social Neuroscience
• +5 more

Paul O'Toole is a Professor of Microbial Genomics and Principal Investigator at the APC Microbiome Ireland, University College Cork. His research focuses on the gut microbiome's role in health, aging, and disease, particularly in the context of diet and probiotics. He leads projects like the ELDERMET study on elderly nutrition and the NU-AGE project exploring Mediterranean diets' anti-aging effects. He holds a BA (Mod.) from Trinity College Dublin and a PhD from Lund University, with postdoctoral training in Canada and New Zealand. Key grants include studies on dairy-derived microbiota, probiotic strain improvement, and microbiome analysis in aging populations. He has published extensively on Lactobacillus genomics, gut-brain interactions, and microbiome-driven health outcomes. His work bridges fundamental microbiology with clinical applications, emphasizing translational research. Scientific highlights include discovering microbiome links to cognitive decline, demonstrating dietary modulation of gut microbes to combat obesity, and identifying keystone species in healthy aging. He advocates for sustainability in conservation and food systems, reflecting his interdisciplinary approach to global health challenges.

• Microbial Genomics
• Gut Microbiome
• Aging and Healthy Aging
• +4 more

Dr. Camilla Nord serves as Assistant Professor of Cognitive Neuroscience at the University of Cambridge's Department of Psychiatry and is Programme Leader at the MRC Cognition and Brain Sciences Unit. She holds dual appointments as Co-Director of Postgraduate Education & Director of the MPhil in Cognitive Neuroscience at the MRC CBU, and as Fellow and Director of Studies at Christ's College Cambridge. Nord directs the Mental Health Neuroscience Lab (nordlab.co.uk), which focuses on translating neuroscience into improved mental health treatments through innovative pharmacological, psychological, and neurostimulation interventions. Her research spans three interconnected streams: Discovery Science investigates brain-body interactions including interoception, circadian rhythms, and metabolism as neglected sources of mental health information; Experimental Medicine employs pharmacological manipulation, brain stimulation, and psychological interventions to establish causal relationships between physiological mechanisms and mental health conditions; and Translational Neuroscience develops clinical trials for neuroscience-based interventions, particularly 'acute augmentations' that enhance psychological therapy efficacy. Her lab has demonstrated how gut states cause disgust avoidance and how psychological therapy techniques alter negative learning processes. Analysis of Nord's publication record reveals a strong emphasis on computational approaches to mental health, with particular focus on depression treatment mechanisms. Her work increasingly integrates brain-body interactions, especially gut-brain and metabolic pathways, into mental health frameworks. Recent publications show growing emphasis on patient-centered research, interoception, and transdiagnostic approaches that cut across traditional psychiatric categories. Wellcome Career Development Award (£1.5 million) Wellcome Mental Health Award (£4.3 million, jointly awarded with Prof. Sarah Garfinkel) Sunday Times Book of the Year (2023) for 'The Balanced Brain: The Science of Mental Health' Financial Times Book of the Year (2023) for 'The Balanced Brain: The Science of Mental Health' Nord actively mentors PhD students and postdoctoral researchers, with her trainees receiving prestigious awards including the British Association of Psychopharmacology (BAP) Poster Prize, BAP Hannah Steinberg Bursary, and Alwyn Lishman Prize. Her lab is currently funded by MRC intramural funding, a Wellcome Career Development Award, and a Wellcome Mental Health Award, supporting innovative research at the intersection of neuroscience and mental health treatment. The Mental Health Neuroscience Lab operates within the MRC Cognition and Brain Sciences Unit, collaborating extensively with researchers across Cambridge and internationally. The lab maintains strong connections with clinical services and patient groups, ensuring research remains grounded in real-world mental health challenges. Current work focuses on transcranial ultrasound stimulation, gut-brain axis interventions, and computational modeling of mental health mechanisms.

• Computational Psychiatry
• Cognitive Neuroscience
• Psychopharmacology
• +7 more

Xiaoyu Cai is an Assistant Professor at the Department of Medicine, Loyola University Chicago, specializing in lung regeneration, aging biology, and stem cell plasticity. Her research focuses on the molecular mechanisms governing alveolar type 2 (AT2) stem cell dynamics during aging and chronic lung diseases. Education: Bachelor of Medicine (Peking University, 2012), Master of Science (Peking University, 2015), PhD in Biology of Aging (USC & Buck Institute, 2021) Key Research Areas: Lung regeneration, inflammation resolution, stem cell aging, 3D organoid cultures Methodologies: Single-cell multiome, mouse genetics, multicellular organoid systems Collaborations: Translational partnerships with clinical teams for bench-to-bedside applications Dr. Cai's recent work explores lineage plasticity in aged lung stem cells, ferroptosis suppression via CRISPR screens, and cellular aging atlases across species. She previously held a postdoctoral position at Genentech Inc. and maintains a professional lab website. Contact: xcai2@luc.edu | Office: CTRE 123

• Lung Regeneration
• Inflammation Resolution
• Aging Biology
• +5 more

Hang Lu is an Associate Professor in the Department of Communication and Media at the University of Michigan's College of Literature, Science, and the Arts. He specializes in science, health, environmental, and risk communication (ComSHER), with a focus on media psychology. His research explores audience responses to media messages about sensitive topics and strategies to enhance message effectiveness. Lu holds a Ph.D. in Communication from Cornell University (2018), along with advanced degrees from Cornell, Marquette University, and Central South University in China. He directs the Media and Risk (MaR) Lab and previously served as a postdoctoral fellow at the Annenberg Public Policy Center. His research spans four main areas: 1) emotion dynamics in media responses, 2) predictors of information behaviors, 3) media effects on stigmatization, and 4) AI applications in sensitive domains. He has published in journals like Journal of Communication , Risk Analysis , and Public Understanding of Science , earning multiple top paper awards. As Vice Chair of the Environmental Communication Division at the International Communication Association, Lu contributes to interdisciplinary dialogue. His work addresses critical societal issues such as climate change communication, vaccination hesitancy, and emerging technology ethics.

• Science Communication
• Health Communication
• Environmental Communication
• +4 more

Kristina Schoonjans is an Associate Professor at EPFL’s School of Life Sciences, where she leads the Laboratory of Metabolic Signaling (UPSCHOONJANS). Her research focuses on the molecular mechanisms of bile acid signaling, nutrient sensing, and intermediary metabolism, particularly in the context of metabolic disorders such as obesity, fatty liver disease, and cancer. She investigates how the liver-gut-brain axis integrates metabolic signals through nuclear receptors and mitochondrial dynamics. Her research interests include: Bile acid signaling and its role as a hormonal regulator Nutrient and metabolite sensing in energy homeostasis Intermediary metabolism and metabolic disorders Role of nuclear receptors (e.g., TGR5, LRH-1) in liver, gut, and adipose tissue Mitochondrial dynamics and fission in metabolic regulation Organoid models for studying liver and intestinal metabolism Systems genetics using BXD mouse populations The most recent articles highlight a strong focus on bile acid signaling, particularly through TGR5 and LRH-1, in regulating metabolic health. Themes include the conversion of white fat to beige fat (beiging), hepatic tumorigenesis, mitochondrial fission, and the use of organoid and genetically engineered mouse models. There is a consistent emphasis on translational applications for obesity, fatty liver disease, and cancer. Scientific honors include: Windaus Prize from the Dr. Falk Foundation (2010, shared with Johan Auwerx) for the discovery of the signaling/endocrine function of bile acids Prof. Schoonjans actively supervises PhD students and has advised numerous doctoral candidates who have since completed their theses. Her lab is supported by multiple grants from Swiss and international funding agencies, including the Swiss National Science Foundation, EPFL, CONACYT, and the Foundation for Health and Education. She teaches in several doctoral programs at EPFL, including Life Sciences Engineering, and contributes to education through the SSV and EDBB/EDCB/EDMS-ENS programs. The Schoonjans Lab brings together scientists, doctoral assistants, and technicians working on projects related to metabolic signaling. The team uses advanced techniques such as genetically modified mouse models, organoid cultures, and multi-omics (metabolomics, proteomics, transcriptomics) to study the liver-gut and brain-liver axes. The lab has a strong track record of high-impact publications and collaborations with institutions worldwide.

• Bile acid signaling
• Nutrient sensing
• Intermediary metabolism
• +11 more

Tural Khudiyev is an Assistant Professor at the Department of Materials Science and Nanotechnology , National University of Singapore (NUS), focusing on multimaterial electronic fibers for human-fabric interaction, soft robotics, and neural probes. He previously worked as a postdoctoral researcher at MIT's Research Laboratory of Electronics. B.Sc. in Nuclear Engineering, Hacettepe University Ph.D. in Materials Science and Nanotechnology, Bilkent University His research spans implantable and wearable electronics , stimuli-responsive drug delivery , and AI in healthcare , with a strong emphasis on scalable nanomanufacturing techniques. His publications in journals like Nature , Nature Nanotechnology , and Advanced Materials highlight innovations in thermally drawn fibers and soft bioelectronic interfaces . Key trends include flexible electronics , machine learning in textiles , and bio-integrated devices , with applications in neural engineering and power textiles . His work has been featured in media outlets such as Reuters and Business Insider . Selected as MIT’s top research story of 2021 #1 Most Read Article in Applied Optics (2015) Featured in Virtual Journal of Nanoscale Science & Technology Khudiyev's contributions to thermally drawn fibers and soft robotics demonstrate interdisciplinary collaboration between materials science, neuroscience, and wearable technology.

• Flexible Electronics
• Soft Robotics
• Bioelectronics
• +3 more

Professor Richelle Mychasiuk, affiliated with the School of Medical Sciences at the University of Sydney, specializes in Sleep Biology and the neurobiological impacts of early life experiences. Her research focuses on how perinatal trauma and adverse childhood events shape neurodevelopment, increasing susceptibility to sleep disturbances, chronic pain, and post-concussive symptomologies in adolescents, with a particular emphasis on sex differences. Education: PhD in Neuroscience Her work explores mechanisms by which early life stressors "under the skin" to alter neuroplasticity and microbiome-gut-brain interactions. She co-founded The GIN hub, integrating Gastroenterology, Immunology, and Neuroscience to study complex chronic disease models. Recent articles highlight her contributions to understanding dietary influences on pain, epigenetic modifications, microbiome depletion effects, and neurovascular interventions in TBI models. Grants: 2025 FMH Start-up Scheme (Faculty of Medicine and Health, University of Sydney) Collaborations: Brain and Mind Centre, University of Sydney; clinical research partnerships for translational studies.

• Sleep Biology
• Neurodevelopment
• Chronic Pain
• +5 more

Elin Org is a Professor of Microbiomics at the University of Tartu's Institute of Genomics, where she also serves as Head of the Estonian Genome Centre and Vice Director of the Institute. Her academic career spans over two decades with significant contributions to microbiome and genomic research. Education: PhD in Genetics, University of Tartu (2006) Master's Degree in Molecular Biotechnology and Biomedicine, University of Tartu (2000) Bachelor's Degree, University of Tartu (1997) Classical Singing, Heino Eller Tartu Music School (1996) Professor Org's research primarily focuses on the intricate relationships between host and gut microbiota and their influence on metabolism and common complex diseases. Her work bridges microbiomics, genomics, and complex disease research, with particular emphasis on understanding how gut microbiome composition affects human health. She has pioneered research connecting long-term antibiotic usage with microbiota-dependent effects and has made significant contributions to understanding the role of gut microbiome in conditions such as gestational diabetes, endometriosis, and polycystic ovary syndrome. Her approach integrates advanced computational methods with comprehensive health data to uncover causal relationships in microbiome research. Her recent publications demonstrate a strong trend toward integrating microbiome data with extensive digital health metrics, using machine learning approaches to identify microbial predictors of health outcomes. This work is increasingly focused on translating microbiome research into clinical applications for disease prediction and personalized medicine approaches, particularly in the context of the Estonian Biobank initiative. Major Scientific Recognition: 2025 National Science Award in medical and health sciences 2023 and 2022: Recognized among the world's top 1% most cited researchers by Clarivate Analytics 2020: Member of AcademiaNet, a portal for top female researchers 2017: EMBO Installation grant 2013: Marie Curie International Outgoing Fellowship Professor Org has secured substantial research funding as principal investigator for multiple significant projects, including 'DISCERN - Discovering the causes of three poorly understood cancers in Europe' (€245,466, European Commission) and 'Improving colorectal cancer screening and prediction using microbiome-based biomarkers' (€760,450, Estonian Research Council). She has served as an opponent for numerous PhD theses across European institutions, contributing to the development of emerging researchers in her field. As Head of the Estonian Genome Centre, Professor Org leads a multidisciplinary research team that plays a crucial role in Estonia's transition from biobanking to personalized medicine applications. She is actively involved in international collaborations through COST networks including INFOGUT (focused on in vitro colon models) and ML4Microbiome (statistical and machine learning techniques in human microbiome studies), positioning her at the forefront of global microbiome research initiatives.

• Microbiomics
• Genomics
• Complex Diseases
• +4 more